441 related articles for article (PubMed ID: 2226466)
1. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.
Ofosu FA; Fareed J; Smith LM; Anvari N; Hoppensteadt D; Blajchman MA
Eur J Biochem; 1992 Jan; 203(1-2):121-5. PubMed ID: 1730217
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
4. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
[TBL] [Abstract][Full Text] [Related]
5. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
Ofosu FA; Modi GJ; Smith LM; Cerskus AL; Hirsh J; Blajchman MA
Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
[TBL] [Abstract][Full Text] [Related]
8. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant mechanisms of Orgaran (Org 10172) and its fraction with high affinity to antithrombin III (Org 10849).
Ofosu FA
Haemostasis; 1992; 22(2):66-72. PubMed ID: 1379966
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII.
Ofosu FA
Haemostasis; 1991; 21(4):240-7. PubMed ID: 1794749
[TBL] [Abstract][Full Text] [Related]
12. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
13. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.
Buchanan MR; Boneu B; Ofosu F; Hirsh J
Blood; 1985 Jan; 65(1):198-201. PubMed ID: 3965047
[TBL] [Abstract][Full Text] [Related]
14. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
Ofosu FA; Modi GJ; Blajchman MA; Buchanan MR; Johnson EA
Biochem J; 1987 Dec; 248(3):889-96. PubMed ID: 2963622
[TBL] [Abstract][Full Text] [Related]
15. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
Ofosu FA; Fernandez F; Gauthier D; Buchanan MR
Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370
[No Abstract] [Full Text] [Related]
16. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
[TBL] [Abstract][Full Text] [Related]
17. Evidence for antithrombin III involvement in the anticoagulant activity of cellulose sulphate.
Kindness G; Long WF; Williamson FB
Br J Pharmacol; 1980 Apr; 68(4):645-9. PubMed ID: 7378640
[TBL] [Abstract][Full Text] [Related]
18. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
[TBL] [Abstract][Full Text] [Related]
19. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
Scully MF; Kakkar VV
Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex.
Rezaie AR
Blood; 2001 Apr; 97(8):2308-13. PubMed ID: 11290592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
